Delivery Order SPE2DB25D3306-SPE2DB25FUCHW
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,253.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adbry 150 mg/mL syringes, with an ultimate completion date of July 22, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $18,567.28 firm-fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has a period of performance through September 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military healthcare system. This award is likely part of a larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,321.32 on July 25, 2025, for the supply of Abyrysvo vial with diluent syringes. This firm fixed price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The contract was competitively awarded with no set-aside designation and will be performed...
- This federal contract award, valued at $2,041.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price contract. The award was not designated with a set-aside requirement, indicating open competition....
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,297.57 fixed-price delivery order contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with a completion date of May 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, valued at $17,904.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of March 18, 2025. The contract provides for the delivery of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of ADBRY 150 MG/ML SYRINGEML. The award, valued at $4,010.47, is a Firm Fixed Price Delivery Order contract with a completion date of June 14, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,083.54 firm fixed-price contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical supply. The contract has an ultimate completion date of May 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $21,247.90 firm fixed-price delivery order covers the supply of the pharmaceutical product ADBRY 150 MG/ML SYRINGEML. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a comprehensive procurement vehicle for a wide range...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,150.03, is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...